Radiation Therapy News and Research

RSS

Radiation therapy (also called radiotherapy, x-ray therapy, or irradiation) is the use of a certain type of energy (called ionizing radiation) to kill cancer cells and shrink tumors. Radiation therapy injures or destroys cells in the area being treated (the “target tissue”) by damaging their genetic material, making it impossible for these cells to continue to grow and divide. Although radiation damages both cancer cells and normal cells, most normal cells can recover from the effects of radiation and function properly. The goal of radiation therapy is to damage as many cancer cells as possible, while limiting harm to nearby healthy tissue.

NYU Langone opens vascular-targeted photodynamic therapy trial to men with localized prostate cancer

NYU Langone Medical Center has begun a clinical trial offering vascular-targeted photodynamic therapy to patients with localized prostate cancer. This novel, minimally invasive procedure uses a light-activated drug to deliver light energy waves by way of laser fibers in order to destroy prostate cancer cells.

28 Jul 2010

CvergenX acquires global rights to InterveneXRT technology for individualization of radiation therapy

Moffitt Cancer Center and CvergenX, Inc., announced today that they have entered into a licensing agreement under which CvergenX has acquired the exclusive worldwide rights to a technology platform that individualizes radiation therapy, InterveneXRT™. Researchers at Moffitt have used gene expression analysis and systems biology to create a radio-sensitivity classification index for individual tumors.

28 Jul 2010

Report shows most men with low PSA undergo aggressive therapy

Most men who are diagnosed with prostate cancer appear to under undergo aggressive therapy, even if they have a low prostate-specific antigen level and low-risk disease, according to a report in the July 26 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

27 Jul 2010

Study on treatment needs of prostate cancer patients with low level PSA

Controversy has long existed over the benefit of the prostate specific antigen (PSA) test used to screen for the presence of prostate cancer, and there has been little study to document the risk profile of men who have a PSA level at or below what is considered 'normal.' New research published in the latest edition of Archives of Internal Medicine (Vol. 170, No. 14) by a team of investigators at The Cancer Institute of New Jersey (CINJ), further explores this population. The findings show that most men with prostate cancer who tested below the normal PSA level and had low-risk disease nevertheless underwent aggressive treatment. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.

27 Jul 2010

Brainlab launches ExacTrac Infrared Monitoring device for patient positioning during radiation therapy

Brainlab announced the availability of ExacTrac® Infrared Monitoring, an add-on device to existing treatment machines for monitoring patient positioning during radiation therapy treatments, at the American Association of Physicists in Medicine (AAPM) Annual Meeting last week.

26 Jul 2010

Glioblastomas patients with affected stem cell niche experience progression-free survival

Patients with deadly glioblastomas who received high doses of radiation that hit a portion of the brain that harbors neural stem cells had double the progression-free survival time as patients who had lower doses or no radiation targeting the area, a study from the Radiation Oncology Department at UCLA's Jonsson Comprehensive Cancer Center has found.

26 Jul 2010

North Shore-LIJ Health System seeks oropharynx patients for phase I clinical trial

The North Shore-LIJ Health System Department of Radiation Medicine announced today it is seeking patients with cancer of the oropharynx (back of the mouth) to participate in a Phase I clinical trial.Subjects must be newly diagnosed and not have undergone any previous treatment. Further, their cancer must be unassociated with the human papilloma virus (HPV-negative), or, if it is HPV-positive, they must be current or former pack-a-day smokers for at least 10 years.

26 Jul 2010

Cancer institute offers new tumor monitoring system for radiation therapy patients

A new system that utilizes a precise a GPS-like system to track prostate cancer tumors is now being offered to patients undergoing radiation therapy at Cedars-Sinai's Samuel Oschin Comprehensive Cancer Institute. The monitoring system, called Calypso, allows radiation beams to more precisely target the cancer as it gives real-time positioning information that allows the radiation beams to focus directly on the cancer.

23 Jul 2010

NVCI, CSN and Workforce CONNECTIONS partner to launch ARRA funded nursing internship program

Nevada Cancer Institute (NVCI) is launching its Plus One Program, a paid nursing internship initiative to equip nursing graduates with advanced training to give them an edge in today's competitive nursing job market. After completing a paid one-year internship at NVCI, participants will become oncology nurses, a highly sought-after specialty. These specialized jobs have the potential to pay increased wages, provide excellent benefits and support articulated career ladders within the field of oncology.

23 Jul 2010

Early bird registration for 2nd International Symposium on MR-guided Focused Ultrasound ends on July 31, 2010

The Focused Ultrasound Surgery Foundation today issued a reminder that early bird registration discounts will end on Saturday, July 31 for the upcoming 2nd International Symposium on MR-guided Focused Ultrasound.

23 Jul 2010

BSD provides additional information to FDA for 510(k) submission of MicroThermX Microwave Ablation System

BSD Medical Corporation today announced that it has provided the additional information requested by the U.S. Food and Drug Administration (FDA) for review of the 510(k) submission the Company filed for premarket clearance of the Company's Phase II MicroThermX® Microwave Ablation System (MTX-180) for ablation of soft tissue.

22 Jul 2010

Hybrid Linac-MR imaging system tracks cancer tumors in real time

Today, at the 52nd Annual Meeting of the American Association of Physicists in Medicine (AAPM) in Philadelphia, a group of researchers from Stanford University will describe the latest developments toward their goal of integrating two existing medical devices -- medical linear accelerators, or "linacs," which produce powerful X-rays for treating cancer, and magnetic resonance imagers (MRIs), which are widely used to image tumors in the human body.

21 Jul 2010

ASTRO accepts 4 abstracts on Stereotactic Body Radiation Therapy for NSCLC

The American Society for Radiation Oncology (ASTRO) has accepted four abstracts from users of Elekta Stereotactic Body Radiation Therapy (SBRT) technology on the use of SBRT to treat non-small cell lung cancer (NSCLC). The clinicians will present their findings during presentations at ASTRO's 52nd Annual Meeting (October 31 - November 4) at the San Diego Convention Center.

From Elekta 20 Jul 2010

Study seeks patients with cancer of oropharynx to participate in Phase I clinical trial of SRS

The North Shore-LIJ Health System Department of Radiation Medicine announced today it is seeking patients with cancer of the oropharynx (back of the mouth)) to participate in a Phase I clinical trial.

20 Jul 2010

Case Western Reserve awarded $0.5M for study of breast cancer in older women

Cynthia Owusu, MD, associate professor at Case Western Reserve University and geriatric-oncologist at University Hospitals Case Medical Center, the School's primary affiliate, has received nearly $500,000 from Susan G. Komen For the Cure to fund a novel three-year study aimed at improving outcomes for older women with newly-diagnosed breast cancer.

20 Jul 2010

IBA Dosimetry to showcase Blue Phantom[2] radiation therapy commissioning solution with LDA-99SC at AAPM

IBA Dosimetry, member of IBA Group, will showcase its latest innovation in radiation therapy commissioning solutions, the Blue Phantom[2] water phantom equipped with advanced Linear Diode Array technology (LDA-99SC), at the American Association of Physicists in Medicine Annual Meeting in Philadelphia, July 18 - 22, 2010.

19 Jul 2010

Proton therapy treatment for anal canal cancer performed for first time in US

The INTEGRIS Cancer Institute of Oklahoma and the ProCure Proton Therapy Center announce a breakthrough treatment approach for anal canal cancer. For the first time in the United States proton therapy is now being used to treat this type of cancer.

17 Jul 2010

An overview of AAPM annual meeting

AAPM is the premier organization in medical physics, a broadly-based scientific and professional discipline encompassing physics principles and applications in medicine and biology. Its membership includes medical physicists who specialize in research that develops cutting-edge technologies and board-certified clinical medical physicists who apply these technologies in community hospitals, clinics, and academic medical centers.

16 Jul 2010

Philadelphia to host 52nd annual meeting of American Association of Physicists in Medicine

Next week the city of Philadelphia will host the 52nd annual meeting of the American Association of Physicists in Medicine (AAPM), the premier organization in medical physics, a broadly-based scientific and professional discipline encompassing physics principles and applications in medicine and biology.

16 Jul 2010

Initial sponsors of 2nd International Symposium on MR-guided Focused Ultrasound announced

The Focused Ultrasound Surgery Foundation has announced that eight leading manufacturers are among the initial sponsors of the 2nd International Symposium on MR-guided Focused Ultrasound, scheduled for October 17 through 20 near Washington, D.C.

From Elekta 16 Jul 2010

Radiation Therapy News and Research

Further Reading

NYU Langone opens vascular-targeted photodynamic therapy trial to men with localized prostate cancer

CvergenX acquires global rights to InterveneXRT technology for individualization of radiation therapy

Report shows most men with low PSA undergo aggressive therapy

Study on treatment needs of prostate cancer patients with low level PSA

Brainlab launches ExacTrac Infrared Monitoring device for patient positioning during radiation therapy

Glioblastomas patients with affected stem cell niche experience progression-free survival

North Shore-LIJ Health System seeks oropharynx patients for phase I clinical trial

Cancer institute offers new tumor monitoring system for radiation therapy patients

NVCI, CSN and Workforce CONNECTIONS partner to launch ARRA funded nursing internship program

Early bird registration for 2nd International Symposium on MR-guided Focused Ultrasound ends on July 31, 2010

BSD provides additional information to FDA for 510(k) submission of MicroThermX Microwave Ablation System

Hybrid Linac-MR imaging system tracks cancer tumors in real time

ASTRO accepts 4 abstracts on Stereotactic Body Radiation Therapy for NSCLC

Study seeks patients with cancer of oropharynx to participate in Phase I clinical trial of SRS

Case Western Reserve awarded $0.5M for study of breast cancer in older women

IBA Dosimetry to showcase Blue Phantom[2] radiation therapy commissioning solution with LDA-99SC at AAPM

Proton therapy treatment for anal canal cancer performed for first time in US

An overview of AAPM annual meeting

Philadelphia to host 52nd annual meeting of American Association of Physicists in Medicine

Initial sponsors of 2nd International Symposium on MR-guided Focused Ultrasound announced

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News